A Concise Enantioselective Formal Synthesis of the Second-Generation Oral Contraceptive Levonorgestrel
This article presents a concise and scalable approach to synthesising a key precursor of the second-generation oral contraceptive levonorgestrel. By combining biocatalysis with established chemical steps, the authors introduce an efficient route that delivers high stereoselectivity, improved process efficiency, and strong potential for cost-effective large-scale production.
Access the full article to explore the complete process development, enzyme engineering strategy, and scale-up insights behind this approach.